WHO makes no (and hereby disclaims any) representations, warranties or guarantees of any kind (whether express or implied)Īs to-and shall have no liability whatsoever arising from-any links, Third Party Sites and/or any content provided therein or accessible therefrom, including, without limitation, any representations, warranties or guarantees as to the The World Health Organization (WHO) provides links to Third Party Sites solely as a convenience to users of this WHO Site. This website and/or database of the World Health Organization (collectively “WHO Site”) may contain links to websites, databases and/or materials developed, sponsored or maintained by third parties unaffiliated with the World Health Organization The second was to support research priorities that contribute to global research platforms in hopes of learning from the current pandemic response to better prepare for the next unforeseen epidemic.Building on the response to recent outbreaks of Ebola virus disease, SARS-CoV and MERS-CoV, the R&D Blueprint has facilitated a coordinated and accelerated response to COVID-19, including an unprecedented program to develop a vaccine, research into potential pharmaceutical treatments and strengthened channels for information sharing between countries. The first was to accelerate innovative research to help contain the spread of the epidemic and facilitate care for those affected. The discussion led to an agreement on two main goals. World scientists on COVID-19 then met at the World Health Organization’s Geneva headquarters on 11–12 February 2020 to assess the current level of knowledge about the new virus, agree on critical research questions that need to be answered urgently, and to find ways to work together to accelerate and fund priority research to curtail this outbreak and prepare for those in the future. On 30 January 2020, following the recommendations of the Emergency Committee, the WHO Director-General declared that the outbreak constitutes a Public Health Emergency of International Concern (PHEIC). The Blueprint aims to improve coordination between scientists and global health professionals, accelerate the research and development process, and develop new norms and standards to learn from and improve upon the global response. The current COVID-19 pandemic is unprecedented, but the global response draws on the lessons learned from other disease outbreaks over the past several decades.Īs part of WHO’s response, the R&D Blueprint was activated to accelerate diagnostics, vaccines and therapeutics for this novel coronavirus.
0 kommentar(er)
